Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind Phase III Study of Oral Pilocarpine for Opioid-Induced Dry Mouth

NCT00003686 is registered in ClinicalTrials.gov with NCIC Clinical Trials Group as lead sponsor.

NCT NCT00003686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind Phase III Study of Oral Pilocarpine for Opioid-Induced Dry Mouth
Lead sponsor
NCIC Clinical Trials Group
Phase
Phase 3
Overall status
Terminated
Start date
May 22, 1998
Completion date
December 15, 2008
Enrollment
4 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

oral complications, quality of life